Assessment of Knowledge and Perceptions of Artificial Intelligence in Solid Organ Transplantation

NCT05932030 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6750

Last updated 2023-07-06

No results posted yet for this study

Summary

The increasing abundance of clinical, genetic, radiological, and metabolic data in transplantation has led to a growing interest in applying artificial intelligence (AI) tools to optimize immunosuppression and overall patient management.

However, the majority of these applications exist only in the preclinical state and the field of artificial intelligence remains unknown to the general public. In view of the potential applications of AI and the growing research interest in this topic, it is essential to assess the knowledge and perceptions of those directly involved in solid organ transplantation.

Primary Objective: To assess the knowledge and perceptions of solid organ transplant patients and healthcare professionals working in the field of solid organ transplantation

Primary endpoint:

* Analysis of verbatim and closed-ended questionnaire data
* Comparison of the averages obtained by the subgroups of patients and health professionals and analysis of the verbatim by grouping them by themes

Conditions

  • Solid Organ Transplantation
  • Artificial Intelligence

Interventions

OTHER

Survey

Submission of a survey to solid organ transplant patients and health professionals working in transplantation to assess their knowledge and perception of the use of artificial intelligence in transplantation

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Pierrick Bedouch, Pr · University Hospital, Grenoble

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-12-01
Completion
2023-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932030 on ClinicalTrials.gov